In vivo experiments show that NNMT-knockdown, NNMT inhibitors and FAO inhibitors can all reduce lung metastases formation, suggesting that targeting NNMT-FAO suppresses the metastatic potential of breast cancer. The gene discussed is NNMT; the disease is breast carcinoma.